DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/5tf5hq/2012_global_cyclos) has announced the addition of the "2012 Global Cyclospora Diagnostics Market Outlook: Test Volume and Sales Forecasts by Country and Market Segment" report to their offering.
The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed.
The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Cyclospora tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Key Topics Covered:
I. Introduction
II. Worldwide Market and Technology Overview
III. France: Test Volume and Diagnostics Sales Forecast by Market Segment
IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment
IX. USA: Test Volume and Diagnostics Sales Forecast by Market Segment
X. Alternative Market Penetration Strategies
XI. Potential Market Entry Barriers and Risks
XII. Competitive Assessments
- Abbott
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Trinity Biotech
- Zenith
- Zeus
For more information visit http://www.researchandmarkets.com/research/5tf5hq/2012_global_cyclos